SearchDictionaryMobileLogin

[Mediators and their antagonists in shock therapy]

AbstractThe list of shock mediators currently comprises more than 150 candidates. A careful analysis using the criteria of Koch-Dale together with decision trees for exclusion of bias revealed that only histamine, C5a, beta-endorphin, tumor necrosis factor (TNF) thromboxane B2, platelet-activating factor (PAF), and oxygen free radicals are shown to be causally associated with shock symptoms. Although experimental studies with inhibitors of these mediators were convincing, there is still a lack of evidence under clinical conditions (exception histamine: anaphylactic shock). Combinations of antagonists against different causal mediators are the most promising future approaches.
AuthorsE Neugebauer, A Leuchleuthner, A Dietrich, S Saad, D Rixen (Affiliation: Biochemische und Experimentelle Abteilung, Universität zu Köln, Bundesrepublik Deutschland.)
JournalLangenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress (Langenbecks Arch Chir Suppl Kongressbd) Pg. 309-18 ( 1991) ISSN: 0942-2854 GERMANY
Vernacular TitleMediatoren und ihre Antagonisten in der Schocktherapie.
PMID1724395 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Acute-Phase Proteins
Topics
  • Acute-Phase Proteins (physiology)
  • Acute-Phase Reaction (physiopathology, therapy)
  • Critical Care (methods)
  • Humans
  • Shock, Surgical (physiopathology, therapy)